Mycobacterium Shinjukuense Pulmonary Disease Progressed to Pleuritis after Iatrogenic Pneumothorax: A Case Report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mycobacterium Shinjukuense Pulmonary Disease Progressed to Pleuritis after Iatrogenic Pneumothorax: A Case Report

Published:2020-05 Issue: Volume:19 Page:100160
ISSN:2405-5794
Container-title:Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
language:en
Short-container-title:Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Author:

Taoka Takashige,Shinohara Tsutomu,Hatakeyama Nobuo,Iwamura Sachiko,Murase Yoshiro,Mitarai Satoshi,Ogushi Fumitaka

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Pulmonary and Respiratory Medicine

Reference15 articles.

1. Mycobacterium shinjukuense sp. nov., a slowly growing, non-chromogenic species isolated from human clinical specimens;Saito;Int J Syst Evol Microbiol,2011

2. Non-tuberculous mycobacterium strains that show positive test for identification kits of M. tuberculosis complex;Aono;Kekkaku,2010

3. Mycobacterium shinjukuense lung disease that was successfully treated with antituberculous drugs;Watanabe;Intern Med,2013

4. Six Cases of Pulmonary Mycobacterium shinjukuense Infection at a Single Hospital;Takeda;Intern Med,2016

5. Intercalation activating fluorescence DNA probe and its application to homogeneous quantification of a target sequence by isothermal sequence amplification in a closed vessel;Ishiguro;Anal Biochem,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution and emergence of Mycobacterium tuberculosis;FEMS Microbiology Reviews;2024-02-14

2. Two Cases of Mycobacterium shinjukuense Pulmonary Disease With a Long-Term Response to Treatment With Clarithromycin, Rifampicin, and Ethambutol;Cureus;2024-01-24

3. Horizontal Gene Transfer and Drug Resistance Involving Mycobacterium tuberculosis;Antibiotics;2023-08-25

4. Mycobacterium shinjukuense infection successfully treated with clarithromycin, rifampicin, and ethambutol;Respiratory Medicine Case Reports;2023

5. Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection;Antimicrobial Agents and Chemotherapy;2022-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3